Prospective cost-effectiveness analysis of genomic profiling in breast cancer

Valesca P. Retel, M. A. Joore, C. A. Drukker, J. M. Bueno-de-Mesquita, M. Knauer, H. van Tinteren, S.C. Linn, Wim H. van Harten*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)3773-3779
JournalEuropean Journal of Cancer
Volume49
Issue number18
DOIs
Publication statusPublished - Dec 2013

Keywords

  • Breast cancer
  • Gene expression profiling
  • Adjuvant systemic treatment
  • Real world cost-effectiveness

Cite this